KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) EPS (Basic): 2012-2025

Historic EPS (Basic) for Sarepta Therapeutics (SRPT) over the last 12 years, with Jun 2025 value amounting to -$4.58.

  • Sarepta Therapeutics' EPS (Basic) fell 1305.26% to -$4.58 in Q2 2025 from the same period last year, while for Jun 2025 it was -$2.18, marking a year-over-year decrease of 303.85%. This contributed to the annual value of $2.47 for FY2024, which is 142.59% up from last year.
  • According to the latest figures from Q2 2025, Sarepta Therapeutics' EPS (Basic) is -$4.58, which was down 374.25% from $1.67 recorded in Q4 2024.
  • In the past 5 years, Sarepta Therapeutics' EPS (Basic) ranged from a high of $1.67 in Q4 2024 and a low of -$5.87 during Q1 2023.
  • Its 3-year average for EPS (Basic) is -$1.47, with a median of $0.35 in 2024.
  • Its EPS (Basic) has fluctuated over the past 5 years, first surged by 176.09% in 2024, then slumped by 1,305.26% in 2025.
  • Quarterly analysis of 5 years shows Sarepta Therapeutics' EPS (Basic) stood at -$1.43 in 2021, then climbed by 13.29% to -$1.24 in 2022, then soared by 161.29% to $0.76 in 2023, then skyrocketed by 119.74% to $1.67 in 2024, then plummeted by 1,305.26% to -$4.58 in 2025.
  • Its last three reported values are -$4.58 in Q2 2025, $1.67 for Q4 2024, and $0.35 during Q3 2024.